Lazard Transactions


DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided

Clear all Clear

Download results

Showing 81 to 90 of 5881 Results

April 01, 2026
Netherlands, United States

Keurig Dr Pepper to Acquire JDE Peet’s and Subsequently Separate into Two Independent Companies – a Leading Refreshment Beverage Player and a Global Coffee Champion

$23 Billion

March 30, 2026
United States

iBase-t Announces Strategic Growth Investment from TA to Accelerate AI-Powered Digital Manufacturing and MRO Transformation in Aerospace & Defense

Undisclosed

March 30, 2026
United Kingdom

Lazard advises Fremman Capital on a continuation fund for Kids Planet

Undisclosed

March 27, 2026
United States

Lazard Advises Aristotle Exchange DCM and DCO on Sale to Underdog

Undisclosed

March 27, 2026
United Kingdom

Videndum plc announces a comprehensive capital structure refinancing, supported by an upsized £85m equity raise

$333.9 Million

March 20, 2026
United States

Falfurrias Launches Crosslakes Next Growth Phase Through Single-Asset Continuation Fund Led by Leonard Green & Partners

Undisclosed

March 20, 2026
Sri Lanka

SriLankan Airlines Completes the Restructuring of its U.S.$175,000,000 Governement-Guaranteed Bonds

$175 Million

March 19, 2026
Czech Republic, Italy

U-Power Group Acquires CERVA Group and Successfully Amends Its Senior Facility Agreement

Undisclosed

March 18, 2026
Italy, United States

Advent and Nextalia announce the signing of binding agreements for the acquisition of a stake in Tinexta from current majority shareholder Tecno Holding and the launch of a mandatory tender offer aimed at the delisting

$1.4 Billion

March 16, 2026
United Kingdom, United States

Paratek Pharmaceuticals Completes Combination with Radius Health, Expanding Its MultiProduct Specialty Commercial Platform

$1.3 Billion